Both in Pharmaceuticals
Opus Genetics vs Canopy Growth
Over the past year IRD returned +85.0% and CGC returned −48.4%; their daily moves had a correlation of 0.10.
IRD +85.0% CGC −48.4%Growth of $1, one year, split-adjusted
| Metric | IRD | CGC |
|---|---|---|
| Price | $3.57 | $0.6657 |
| Market cap | $297.0M | $281.6M |
| Today | +3.18% | −2.72% |
| 1 month | −28.0% | −28.0% |
| 6 months | −23.6% | −38.9% |
| Year to date | +77.6% | −41.6% |
| 1 year | +78.5% | −49.6% |
| Revenue growth (YoY) | −73.8% | +7.8% |
| Gross margin | 100.0% | 27.4% |
| Net margin | −1072.6% | −18.0% |
| P/E (TTM) | — | — |
| Price / sales | 30.1× | 1.2× |
| Net cash | $53.9M | $67.9M |
| Dividend yield | — | — |
| Volatility (60d) | 91.4% | 40.5% |
| Short % of float | 21.4% | 7.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).